You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

Pharma/Bio Industry Ramping Up Aseptic Fill/Finish Capacity to Combat Pandemic, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 149 Words
Attachment: Map

In the Pharma/Bio Industry, aseptic fill/finish manufacturing is the aseptic filling of biological drugs or medicines in any form, such as sterile liquid, powder and suspension, in vials, ampoules, bottles syringes and cartridges after the product is produced. As such, the sector is anticipated to play a big role in the manufacture of COVID-19 vaccines.

It is not uncommon that a manufacturer does not have fill/finish capabilities on site. Instead, it is a common practice that the bulk drug substance is made by one manufacturer and shipped to a second site, sometimes a contractor, to fill the final drug product.

Subscribe Now! All Fields Required...

Standard Membership - Free